Hussein M. Eid

968 total citations
24 papers, 744 citations indexed

About

Hussein M. Eid is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Hussein M. Eid has authored 24 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Hussein M. Eid's work include Advanced Drug Delivery Systems (13 papers), Advancements in Transdermal Drug Delivery (11 papers) and Berberine and alkaloids research (3 papers). Hussein M. Eid is often cited by papers focused on Advanced Drug Delivery Systems (13 papers), Advancements in Transdermal Drug Delivery (11 papers) and Berberine and alkaloids research (3 papers). Hussein M. Eid collaborates with scholars based in Egypt, Saudi Arabia and United Kingdom. Hussein M. Eid's co-authors include Mohammed H. Elkomy, Adel A. Ali, Shahira F. El Menshawe, Izzeddin Alsalahat, Heba F. Salem, Ibrahim A. Naguib, Ahmed Mahmoud Abdelhaleem Ali, Mohammed Elmowafy, Ameeduzzafar Zafar and Khaled Shalaby and has published in prestigious journals such as Journal of Controlled Release, Journal of Pharmaceutical Sciences and Pharmaceutics.

In The Last Decade

Hussein M. Eid

22 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hussein M. Eid Egypt	15	476	193	137	70	64	24	744
Dignesh Khunt India	16	539 1.1×	255 1.3×	154 1.1×	42 0.6×	42 0.7×	40	886
Brijesh Shah India	13	527 1.1×	317 1.6×	152 1.1×	43 0.6×	34 0.5×	18	880
Marcelle Silva-Abreu Spain	13	301 0.6×	112 0.6×	104 0.8×	41 0.6×	83 1.3×	26	597
Majid Tabbakhian Iran	13	560 1.2×	281 1.5×	145 1.1×	20 0.3×	68 1.1×	29	847
Vahid Ramezani Iran	15	249 0.5×	227 1.2×	69 0.5×	34 0.5×	48 0.8×	40	753
Nevine Shawky Abdelmalak Egypt	13	430 0.9×	172 0.9×	98 0.7×	15 0.2×	35 0.5×	23	666
Shahira F. El Menshawe Egypt	9	300 0.6×	114 0.6×	56 0.4×	32 0.5×	49 0.8×	14	449
María Antonia Egea Spain	9	493 1.0×	204 1.1×	179 1.3×	68 1.0×	212 3.3×	11	847
Çetin Taş Türkiye	14	499 1.0×	107 0.6×	71 0.5×	31 0.4×	72 1.1×	29	681
Susbin Raj Wagle Australia	14	127 0.3×	189 1.0×	74 0.5×	75 1.1×	36 0.6×	54	646

Countries citing papers authored by Hussein M. Eid

Since Specialization

Citations

This map shows the geographic impact of Hussein M. Eid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein M. Eid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein M. Eid more than expected).

Fields of papers citing papers by Hussein M. Eid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein M. Eid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein M. Eid. The network helps show where Hussein M. Eid may publish in the future.

Co-authorship network of co-authors of Hussein M. Eid

This figure shows the co-authorship network connecting the top 25 collaborators of Hussein M. Eid. A scholar is included among the top collaborators of Hussein M. Eid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hussein M. Eid. Hussein M. Eid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eid, Hussein M., et al.. (2025). Development of Novel Olmesartan Medoxomil Loaded Leciplex for Enhanced Oral Bioavailability: Formulation, Histopathological Analysis, and In Vivo Pharmacokinetic Studies. Journal of Pharmaceutical Innovation. 21(1).

Eid, Hussein M., et al.. (2025). Nose-to-brain delivery of chitosan coated Leciplex containing zopiclone for improved management of epilepsy: Formulation, pharmacokinetics, and Pharmacodynamics. Journal of Drug Delivery Science and Technology. 111. 107078–107078. 2 indexed citations

Eid, Hussein M., et al.. (2025). Tunable nanospanlastics for 18α-Glycyrrhetinic acid brain targeted delivery to manage cognitive deficits and misfolded protein aggregates in Alzheimer's disease: In vitro optimization and in vivo pharmacodynamics assessment. Journal of Drug Delivery Science and Technology. 116. 107959–107959.

Hendawy, Omnia M., Mohammed H. Elkomy, Ahmed Mahmoud Abdelhaleem Ali, et al.. (2025). Nose-to-Brain Delivery of Armodafinil Loaded Spanlastics in Situ Gel: Formulation, Statistical Optimization, and Pharmacokinetics Evaluation. Journal of Pharmaceutical Innovation. 20(6). 2 indexed citations

Azmy, Ahmed F., et al.. (2024). The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects. International Microbiology. 28(2). 227–239. 6 indexed citations

Alsaidan, Omar Awad, et al.. (2024). Brain targeting of venlafaxine via intranasal transbilosomes thermogel for improved management of depressive disorder. Journal of Pharmaceutical Sciences. 113(11). 3304–3314. 10 indexed citations

Eid, Hussein M., et al.. (2024). A Novel Chitosan-coated Leciplex Loaded with Ambrisentan as a Possible Pulmonary Nanosystem: Optimization, Characterization, and Pharmacokinetics Assessments. Journal of Pharmaceutical Sciences. 113(8). 2320–2330. 12 indexed citations

Elkomy, Mohammed H., Omnia M. Hendawy, Randa Mohammed Zaki, et al.. (2024). Intranasal trimethyl chitosan-coated emulsomes containing tizanidine as brain-targeted therapy in spasticity: formulation, optimization, and pharmacokinetic assessment. Drug Delivery and Translational Research. 15(7). 2565–2580. 5 indexed citations

Elkomy, Mohammed H., Fatma I. Abo El‐Ela, Randa Mohammed Zaki, et al.. (2023). Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model. Pharmaceutics. 15(8). 2095–2095. 14 indexed citations

10.

Elkomy, Mohammed H., Randa Mohammed Zaki, Omar Awad Alsaidan, et al.. (2023). Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies. Pharmaceutics. 15(7). 1805–1805. 24 indexed citations

11.

Tulbah, Alaa S., Mohammed H. Elkomy, Randa Mohammed Zaki, et al.. (2023). Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures. International Journal of Pharmaceutics X. 6. 100206–100206. 14 indexed citations

12.

Elkomy, Mohammed H., Adel A. Ali, & Hussein M. Eid. (2022). Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review. Journal of Controlled Release. 351. 923–940. 96 indexed citations

13.

Elkomy, Mohammed H., et al.. (2022). Fabrication and In Vitro/In Vivo Appraisal of Metronidazole Intra-Gastric Buoyant Sustained-Release Tablets in Healthy Volunteers. Pharmaceutics. 14(4). 863–863. 13 indexed citations

14.

Elkomy, Mohammed H., Nabil K. Alruwaili, Mohammed Elmowafy, et al.. (2022). Surface-Modified Bilosomes Nanogel Bearing a Natural Plant Alkaloid for Safe Management of Rheumatoid Arthritis Inflammation. Pharmaceutics. 14(3). 563–563. 66 indexed citations

15.

Elkomy, Mohammed H., Hussein M. Eid, Adel A. Ali, et al.. (2022). Intranasal Delivery of Granisetron to the Brain via Nanostructured Cubosomes-Based In Situ Gel for Improved Management of Chemotherapy-Induced Emesis. Pharmaceutics. 14(7). 1374–1374. 37 indexed citations

16.

Panda, Dibya Sundar, et al.. (2021). Berberine Encapsulated Lecithin–Chitosan Nanoparticles as Innovative Wound Healing Agent in Type II Diabetes. Pharmaceutics. 13(8). 1197–1197. 51 indexed citations

17.

Eid, Hussein M., et al.. (2021). Novel Chitosan-Coated Niosomal Formulation for Improved Management of Bacterial Conjunctivitis: A Highly Permeable and Efficient Ocular Nanocarrier for Azithromycin. Journal of Pharmaceutical Sciences. 110(8). 3027–3036. 53 indexed citations

18.

Elkomy, Mohammed H., Mohammed Elmowafy, Khaled Shalaby, et al.. (2021). Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis. Drug Development and Industrial Pharmacy. 47(2). 246–258. 36 indexed citations

19.

Eid, Hussein M., Mohammed H. Elkomy, Shahira F. El Menshawe, & Heba F. Salem. (2019). Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: the Influence of Pegylation and Chitosan Coating. AAPS PharmSciTech. 20(5). 183–183. 71 indexed citations

20.

Eid, Hussein M., Mohammed H. Elkomy, Shahira F. El Menshawe, & Heba F. Salem. (2019). Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study. Journal of Drug Delivery Science and Technology. 54. 101304–101304. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact